Barrington Research Issues Pessimistic Forecast for Option Care Health (NASDAQ:OPCH) Stock Price

Option Care Health (NASDAQ:OPCH) had its price objective dropped by equities research analysts at Barrington Research from $40.00 to $32.00 in a report issued on Thursday, Benzinga reports. The firm presently has an “outperform” rating on the stock. Barrington Research’s target price would suggest a potential upside of 39.62% from the stock’s previous close.

Several other equities analysts also recently commented on the stock. Bank of America downgraded shares of Option Care Health from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $43.00 to $29.00 in a report on Wednesday. Jefferies Financial Group cut shares of Option Care Health from a “buy” rating to a “hold” rating and decreased their price target for the stock from $38.00 to $26.00 in a research note on Thursday. Finally, JMP Securities increased their price objective on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a report on Monday, September 30th.

Option Care Health Price Performance

NASDAQ:OPCH opened at $22.92 on Thursday. The business’s 50-day simple moving average is $30.81 and its two-hundred day simple moving average is $30.02. Option Care Health has a 52 week low of $22.91 and a 52 week high of $34.63. The stock has a market cap of $3.92 billion, a PE ratio of 19.75, a P/E/G ratio of 2.31 and a beta of 1.29. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCH) last released its earnings results on Wednesday, October 30th. The company reported $0.36 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.31 by $0.05. Option Care Health had a return on equity of 14.82% and a net margin of 4.60%. The firm had revenue of $1.28 billion during the quarter, compared to analysts’ expectations of $1.22 billion. As a group, analysts forecast that Option Care Health will post 1.22 EPS for the current fiscal year.

Insider Transactions at Option Care Health

In related news, CFO Michael H. Shapiro sold 23,217 shares of the firm’s stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the sale, the chief financial officer now owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the transaction, the director now directly owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the company’s stock in a transaction on Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total value of $718,566.15. Following the transaction, the chief financial officer now directly owns 247,317 shares in the company, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 0.64% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. Blue Trust Inc. grew its stake in shares of Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company’s stock worth $81,000 after acquiring an additional 377 shares during the last quarter. GAMMA Investing LLC grew its position in Option Care Health by 110.6% during the 3rd quarter. GAMMA Investing LLC now owns 897 shares of the company’s stock worth $28,000 after purchasing an additional 471 shares during the last quarter. Trust Point Inc. increased its stake in Option Care Health by 2.6% during the 3rd quarter. Trust Point Inc. now owns 24,124 shares of the company’s stock valued at $755,000 after purchasing an additional 622 shares in the last quarter. Nisa Investment Advisors LLC increased its stake in Option Care Health by 5.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 13,581 shares of the company’s stock valued at $376,000 after purchasing an additional 690 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in shares of Option Care Health by 3.8% in the third quarter. State of Alaska Department of Revenue now owns 19,871 shares of the company’s stock worth $621,000 after buying an additional 735 shares during the last quarter. 98.05% of the stock is owned by institutional investors and hedge funds.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.